Orthotopic administration of 213Bi-bevacizumab inhibits progression of PC3 xenografts in the prostate
- S. M. A. Rizvi
- , B. J. Allen
- , C. S. Lee
- , F. Bruchertseifer
- , C. Apostolidis
- , A. Morgenstern
- , R. A. Clarke
Research output: Contribution to journal › Article › peer-review
5
Citations
(Scopus)